C4 Therapeutics, Inc.·4

Sep 29, 6:33 PM ET

Prokupets Elena 4

4 · C4 Therapeutics, Inc. · Filed Sep 29, 2021

Insider Transaction Report

Form 4
Period: 2021-09-27
Transactions
  • Sale

    Common Stock

    2021-09-27$50.04/sh1,311$65,604503,126 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-27$50.04/sh539$26,96931,681 total(indirect: By Spouse)
Footnotes (5)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F5]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION